Securities Code: 002424 Securities Abbreviation: ST Bailing Announcement Number: 2026-020
Guizhou Bai Ling Enterprise Group Pharmaceutical Co., Ltd. Announcement on the Resolutions of the 25th Meeting of the 6th Board of Directors
The company and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, and contains no false records, misleading statements, or significant omissions.
I. Convening of the Meeting
-
The 25th Meeting of the 6th Board of Directors of Guizhou Bai Ling Enterprise Group Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") was convened by Mr. Niu Min, Acting Chairman of the Company. The meeting notice was issued on April 16, 2026, through personal delivery, email, telephone, and other communication methods.
-
The Board meeting was held on April 27, 2026, at 10:00 AM in the third-floor conference room of the Company, through a combination of on-site and telecommunication methods.
-
A total of 8 directors were required to attend this Board meeting, and 7 directors actually attended. Director Jiang Yong entrusted Director Niu Min to attend and vote on his behalf. Independent Directors Yang Ming, Hu Jian, and Zhang Hongwu voted via telecommunication.
-
The meeting was presided over by Acting Chairman Niu Min. Senior management personnel of the Company attended the meeting.
-
The convening and holding of this Board meeting complied with the provisions of the "Company Law," the "Articles of Association," the "Board Meeting Rules of Procedure," and relevant laws and regulations.